Clinical Trial Update: Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab alone or in combination with relatlimab or ipilimumab for locally advanced unresectable or metastatic basal cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Relatlimab (relatlimab)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Basal Cell Carcinoma | Phase 2 | Status: RECRUITING